Announcement of the Intent To Award Single-Source Grants to the National Association of Area Agencies on Aging and the National Association of States United for Aging and Disabilities, 54289 [2015-22631]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 174 / Wednesday, September 9, 2015 / Notices
to residents of Illinois with funding
from the Retirement Research
Foundation. Additional funds are
needed to leverage the foundation’s
funding, in order to ensure that the
current provision of services to Illinois
residents will be continued. This
supplementary funding would be
provided for the approved period.
Authority: This program is authorized
under Title II of the Older Americans Act
(OAA) (42 U.S.C. 3032), as amended by the
Older Americans Act Amendments of 2006,
Public Law 109–365.
(Catalog of Federal Domestic Assistance
93.048).
Dated: August 14, 2015.
Kathy Greenlee,
Assistant Secretary for Aging and
Administrator, Administration for
Community Living.
[FR Doc. 2015–22630 Filed 9–8–15; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Announcement of the Intent To Award
Single-Source Grants to the National
Association of Area Agencies on
Aging and the National Association of
States United for Aging and
Disabilities
Administration for Community
Living, HHS.
ACTION: Notice.
AGENCY:
The Administration for
Community Living (ACL) announces the
intent to award, subject to the
availability of funds, single-source grant
awards in the amount of $335,000 to the
National Association of Area Agencies
on Aging (n4a) and $153,500 to the
National Association of State United for
Aging and Disabilities (NASUAD). The
awards will continue supporting and
stimulating the ongoing work by these
organizations to further develop and
assist states and community-based
organizations with building their
business capacity for managed longterm services and supports and delivery
system reform. CFDA Numbers: 93.048
DATES: The awards will be issued for a
project period of September 30, 2015
through September 29, 2016.
FOR FURTHER INFORMATION CONTACT:
Marisa Scala-Foley, Office of Integrated
Care Innovations, Administration for
Community Living, 1 Massachusetts
Avenue NW., Washington, DC 20001.
Telephone: 202–357–3516; Email:
Marisa.Scala-Foley@acl.hhs.gov.
Lhorne on DSK5TPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
14:19 Sep 08, 2015
Jkt 235001
In 2012,
n4a and NASUAD were awarded grants
from ACL to build the business capacity
of state and community-based aging and
disability organizations for managed
long-term services and supports
(MLTSS). This one-year of grant
funding, through continuation grant,
will continue to support n4a and
NASUAD in their efforts to:
• Identify and track emerging trends,
best practices, barriers, lessons learned
and progress in the aging and disability
networks’ integration into MLTSS and
delivery system reform;
• increase state and community-based
aging and disability organizations’
capacity, readiness and involvement in
the provision of MLTSS through the
provision of broad-based and targeted
technical assistance, education and
training; and
• develop products that complement
and enhance the first two areas of focus.
This program is authorized under the
Older Americans Act of 1965, as
amended in 2006, Public Law 109–365.
SUPPLEMENTARY INFORMATION:
Dated: August 28, 2015.
Sharon Lewis,
Principal Deputy Administrator,
Administration for Community Living.
[FR Doc. 2015–22631 Filed 9–8–15; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–D–1213]
Use of Donor Screening Tests To Test
Donors of Human Cells, Tissues, and
Cellular and Tissue-Based Products
for Infection With Treponema pallidum
(Syphilis); Guidance for Industry;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a
document entitled ‘‘Use of Donor
Screening Tests to Test Donors of
Human Cells, Tissues and Cellular and
Tissue-Based Products for Infection
with Treponema pallidum (Syphilis);
Guidance for Industry.’’ The guidance
document provides establishments that
make donor eligibility determinations
for donors of human cells, tissues, and
cellular and tissue-based products
(HCT/P Establishments) with updated
recommendations concerning donor
testing for evidence of Treponema
pallidum (T. pallidum) infection, the
SUMMARY:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
54289
etiologic agent of syphilis. HCT/P
Establishments must, as required under
Federal regulations, test a donor
specimen for evidence of T. pallidum
infection using appropriate FDAlicensed, approved, or cleared donor
screening tests, in accordance with the
manufacturer’s instructions, unless an
exception to this requirement applies.
The guidance clarifies that FDA does
not consider diagnostic tests or preamendment devices (which have not
been licensed, approved, or cleared) to
be adequate for use in donor testing for
T. pallidum infection under the criteria
specified in Federal regulations. The
guidance announced in this notice
finalizes the draft guidance of the same
title, dated October 2013. The
recommendations in the guidance
announced in this notice supersedes
those recommendations for testing HCT/
P donors for evidence of T. pallidum
infection contained in the document
entitled ‘‘Guidance for Industry:
Eligibility Determination for Donors of
Human Cells, Tissues, and Cellular and
Tissue-Based Products (HCT/Ps),’’ dated
August 2007.
DATES: Submit either electronic or
written comments on Agency guidances
at any time.
ADDRESSES: Submit written requests for
single copies of the guidance to the
Office of Communication, Outreach and
Development, Center for Biologics
Evaluation and Research (CBER), Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 71, Rm. 3128,
Silver Spring, MD 20993–0002. Send
one self-addressed adhesive label to
assist the office in processing your
requests. The guidance may also be
obtained by mail by calling CBER at 1–
800–835–4709 or 240–402–8010. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the guidance
document.
Submit electronic comments on the
guidance to https://www.regulations.gov.
Submit written comments to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852.
FOR FURTHER INFORMATION CONTACT: Paul
E. Levine, Jr., Center for Biologics
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 71, Rm. 7301,
Silver Spring, MD 20993–0002, 240–
402–7911.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of
a document entitled ‘‘Use of Donor
Screening Tests to Test Donors of
E:\FR\FM\09SEN1.SGM
09SEN1
]]>Agencies
[Federal Register Volume 80, Number 174 (Wednesday, September 9, 2015)]
[Notices]
[Page 54289]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-22631]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Community Living
Announcement of the Intent To Award Single-Source Grants to the
National Association of Area Agencies on Aging and the National
Association of States United for Aging and Disabilities
AGENCY: Administration for Community Living, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Administration for Community Living (ACL) announces the
intent to award, subject to the availability of funds, single-source
grant awards in the amount of $335,000 to the National Association of
Area Agencies on Aging (n4a) and $153,500 to the National Association
of State United for Aging and Disabilities (NASUAD). The awards will
continue supporting and stimulating the ongoing work by these
organizations to further develop and assist states and community-based
organizations with building their business capacity for managed long-
term services and supports and delivery system reform. CFDA Numbers:
93.048
DATES: The awards will be issued for a project period of September 30,
2015 through September 29, 2016.
FOR FURTHER INFORMATION CONTACT: Marisa Scala-Foley, Office of
Integrated Care Innovations, Administration for Community Living, 1
Massachusetts Avenue NW., Washington, DC 20001. Telephone: 202-357-
3516; Email: Marisa.Scala-Foley@acl.hhs.gov.
SUPPLEMENTARY INFORMATION: In 2012, n4a and NASUAD were awarded grants
from ACL to build the business capacity of state and community-based
aging and disability organizations for managed long-term services and
supports (MLTSS). This one-year of grant funding, through continuation
grant, will continue to support n4a and NASUAD in their efforts to:
Identify and track emerging trends, best practices,
barriers, lessons learned and progress in the aging and disability
networks' integration into MLTSS and delivery system reform;
increase state and community-based aging and disability
organizations' capacity, readiness and involvement in the provision of
MLTSS through the provision of broad-based and targeted technical
assistance, education and training; and
develop products that complement and enhance the first two
areas of focus.
This program is authorized under the Older Americans Act of 1965,
as amended in 2006, Public Law 109-365.
Dated: August 28, 2015.
Sharon Lewis,
Principal Deputy Administrator, Administration for Community Living.
[FR Doc. 2015-22631 Filed 9-8-15; 8:45 am]
BILLING CODE 4154-01-P
